Plus, video footage of the event – featuring our very own Kelly Close!

Paving the way to healthier food options and preventing heart disease.

Smartphone user interface with no screen or buttons on the pump! Launch: 2018?

Clinical trial currently enrolling for type 2 diabetes – find out if you qualify for this study.

Seeking to reach over 31,000 older adults with prediabetes over the next two years.

Pivotal trial to start in early 2017. What does glucagon add to automated insulin delivery?

Varying perspectives on a touchy subject, from Kerri Sparling of Six Until Me.

Will this drug be cheaper than Lantus and other insulins?

"Non-compliance is a term that is banned in my unit…"

New two-year study suggests red wine is beneficial for cholesterol levels.

My somewhat-impatient response to the recent New York Times article, “Some Older Patients Are Treated Not Wisely, but Too Much.”

Another move from northern California to combat childhood obesity.

One rose can bring a month’s supply of insulin to a child who badly needs it.

Breaking news from Stockholm, Sweden, where our team is on the ground at the European Association for the Study of Diabetes (EASD) Conference – one of the largest...

Behavioral expert Dr. Bill Polonsky on how providers and caregivers can reframe diabetes conversations.

Award honors innovations to personalize care.

The DreaMed Pump Advisor, Glooko app, Nutshell, and MyStar DoseCoach.

Gamechanging Xultophy (Tresiba + Victoza) also now submitted to the FDA.

Bringing added convenience to blood glucose monitoring in smartphone-connected device.

Why we’re fans of the newest Bluetooth-enabled meter with an FDA-approved bolus advisor app.